InvestorsHub Logo
Followers 25
Posts 1133
Boards Moderated 0
Alias Born 04/04/2012

Re: None

Wednesday, 12/02/2020 9:56:24 PM

Wednesday, December 02, 2020 9:56:24 PM

Post# of 894
$MACK:Merrimack sold its oncology portfolio to Ipsen in April 2017 for
$575M
in upfront cash. MACK is eligible to receive up to an additional
$450M
triggered by the approval of additional indications for Onivyde in the U.S., a bullish prospect considering its current market cap of ~
$77M
seekingalpha.com/news/36409...